Genmab A/S
BISPECIFIC ANTIBODIES AGAINST HER2

Last updated:

Abstract:

Bispecific antibodies which comprise antigen-binding regions binding to two different epitopes of human epidermal growth factor receptor 2 (HER2), and related antibody-based compositions and molecules, are disclosed. Pharmaceutical compositions comprising the antibodies and methods of preparing and using the antibodies are also disclosed.

Status:
Application
Type:

Utility

Filling date:

14 Jan 2021

Issue date:

21 Oct 2021